These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 14684442)

  • 1. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.
    Laruelle M; Kegeles LS; Abi-Dargham A
    Ann N Y Acad Sci; 2003 Nov; 1003():138-58. PubMed ID: 14684442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
    Laruelle M; Frankle WG; Narendran R; Kegeles LS; Abi-Dargham A
    Clin Ther; 2005; 27 Suppl A():S16-24. PubMed ID: 16198197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: from dopaminergic to glutamatergic interventions.
    Laruelle M
    Curr Opin Pharmacol; 2014 Feb; 14():97-102. PubMed ID: 24524997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review.
    Stone JM; Morrison PD; Pilowsky LS
    J Psychopharmacol; 2007 Jun; 21(4):440-52. PubMed ID: 17259207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum.
    Cepeda C; Levine MS
    Dev Neurosci; 1998; 20(1):1-18. PubMed ID: 9600386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.
    Yang CR; Chen L
    Neuroscientist; 2005 Oct; 11(5):452-70. PubMed ID: 16151046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate and schizophrenia: beyond the dopamine hypothesis.
    Coyle JT
    Cell Mol Neurobiol; 2006; 26(4-6):365-84. PubMed ID: 16773445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
    Abi-Dargham A; Moore H
    Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.
    Krystal JH; Anand A; Moghaddam B
    Arch Gen Psychiatry; 2002 Jul; 59(7):663-4. PubMed ID: 12090822
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic responses in the core part of the nucleus accumbens to subcutaneous MK801 administration are increased following postnatal transient blockade of the prefrontal cortex.
    Tagliabue E; Pouvreau T; Eybrard S; Meyer F; Louilot A
    Behav Brain Res; 2017 Sep; 335():191-198. PubMed ID: 28823626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
    Sarantis K; Matsokis N; Angelatou F
    Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropathology of schizophrenia.
    Bachus SE; Kleinman JE
    J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies.
    Abi-Dargham A; Laruelle M
    Eur Psychiatry; 2005 Jan; 20(1):15-27. PubMed ID: 15642439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task.
    Carli M; Invernizzi RW
    Front Neural Circuits; 2014; 8():58. PubMed ID: 24966814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex.
    Del Arco A; Mora F
    Pharmacol Biochem Behav; 2008 Aug; 90(2):226-35. PubMed ID: 18508116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia.
    Deutch AY
    J Neural Transm Suppl; 1992; 36():61-89. PubMed ID: 1527521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.